Ovarian Cancer Response Scoring (OCRS): Validation of a system to quantify histopathological response to neoadjuvant chemotherapy in high-grade serous ovarian cancer

被引：0
|
作者：
Singh, N. [1 ]
Said, I. [1 ]
Faruqi, A. [1 ]
Gilks, B. [1 ]
Le, N. [1 ]
Boehm, S. [1 ]
机构：
[1] Barts Hlth NHS Trust, Dept Cellular Pathol, London, England
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-14-004
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Development of a Response Scoring System to Quantify the Effect of Neoadjuvant Chemotherapy in Ovarian Cancer - Ovarian Cancer Response Scoring (OCRS) Study
    Boehm, S.
    Said, I.
    Faruqi, A.
    Gilks, C. B.
    Singh, N.
    [J]. MODERN PATHOLOGY, 2014, 27 : 276A - 277A
  • [2] Development of a Response Scoring System to Quantify the Effect of Neoadjuvant Chemotherapy in Ovarian Cancer Ovarian Cancer Response Scoring (OCRS) Study
    Boehm, S.
    Said, I.
    Faruqi, A.
    Gilks, C. B.
    Singh, N.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 276A - 277A
  • [3] External validation of chemotherapy response scoring system for histopathologic assessment of tumor regression after neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Lee, J. Y.
    Nam, E. J.
    Kim, S. W.
    Kim, S.
    Kim, Y. T.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 118 - 118
  • [4] Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
    Boehm, Steffen
    Faruqi, Asma
    Said, Ian
    Lockley, Michelle
    Brockbank, Elly
    Jeyarajah, Arjun
    Fitzpatrick, Amanda
    Ennis, Darren
    Dowe, Thomas
    Santos, Jennifer L.
    Cook, Linda S.
    Tinker, Anna V.
    Le, Nhu D.
    Gilks, C. Blake
    Singh, Naveena
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (22) : 2457 - U73
  • [5] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [6] Chemotherapy Response Score: Validation of a 3-Tier Histopathological Scoring System for Assessing Response To Neoadjuvant Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma
    Singh, Naveena
    Gilks, C. Blake
    Faruqi, Asma
    Said, Ian
    Tinker, Anna
    Le, Nhu
    Boehm, Steffen
    [J]. MODERN PATHOLOGY, 2015, 28 : 308A - 308A
  • [7] Chemotherapy Response Score: Validation of a 3-Tier Histopathological Scoring System for Assessing Response To Neoadjuvant Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma
    Singh, Naveena
    Gilks, C. Blake
    Faruqi, Asma
    Said, Ian
    Tinker, Anna
    Le, Nhu
    Boehm, Steffen
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 308A - 308A
  • [8] Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
    Montgomery, A. M.
    Crossman, D. K.
    Yang, E. S.
    Alvarez, R. D.
    Huh, W. K.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    Arend, R. C.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 12 - 13
  • [9] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
  • [10] The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.
    Zhu, Lei
    Cao, Guangming
    Hua, Dingchao
    Cui, Lina
    Zhao, Xiaochen
    Wang, Shuzhen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17605 - E17605
12345